Fibromyalgia: The Newest Psychiatric Market
This article was originally published in Start Up
Executive Summary
Cypress Bioscience has reinvented itself in the past year to focus on the development of drugs for fibromyalgia syndrome, a mysterious disease characterized by pain and sleeplessness in the absence of measurable pathophysiological features.